Specialties

A 56-year old male with type 2 diabetes and stage 3 chronic kidney disease contacted us recently regarding his new prescription for the SGLT2 inhibitor canagliflozin (Invokana)....

Earlier onset of type 2 diabetes equals higher risk of kidney transplant.

A recent population-based cohort study offers more insight into the link between glycemic status and the risk for PD.

Lifestyle modifications can impact cardiovascular outcomes including myocardial infarction, strokes, and death. 

Compelling evidence suggests that the age of diabetes diagnosis may be linked to the risk of end-stage kidney disease. 

Results from the VERTIS-CV trial suggest that ertugliflozin is not superior to placebo in reducing MACE but may reduce the rate of hospitalization for heart failure. 

Increased pericardial adipose tissue volume leads to coronary heart disease, coronary artery calcification, atrial fibrillation, and reduced left ventricular function. 

Getting an annual flu vaccine could help lower complications associated with diabetes.  

Beneficial cardiovascular results were consistent across subgroups regardless of diabetes status or medication combinations.

Guest Author: Dr. Cyaandi R. Dove, D.P.M
A recent trial showed a significant reduction in wound area by 73.1% with Single Use Negative Pressure Wound Therapy System (sNPWT).